• locale

  United States

• market

  PRIVATE

• industry

  Biotechnology

• website

  www.bioeclipse.com/

BioEclipse Therapeutics focuses on developing immunotherapies for cancer treatment, specifically targeting solid tumors and enhancing patient responses through combined therapies involving immune cells and oncolytic viruses. The company is currently advancing its product, CRX100, through clinical trials.